LONG-TERM SAFETY OF TOCILIZUMAB IN RA PATIENTS TREATED FOR A MEAN DURATION OF 3.7 YEARS Genovese, M., Sebba, A., Rubbert-Roth, A., Scali, J. J., Alten, R., Kremer, J. M., Pitts, L., Vernon, E., van Vollenhoven, R. F. OXFORD UNIV PRESS. 2013: 93–94

View details for Web of Science ID 000318569000261